Cargando…

Hepatitis B Reactivation with Novel Agents in Non-Hodgkin’s Lymphoma and Prevention Strategies

Hepatitis B virus (HBV) infection remains an endemic disease in most parts of the world despite available prophylactic vaccines. Non-Hodgkin’s lymphoma is the most common hematological malignancy, and certain patients undergoing therapy are at increased risk of HBV reactivation. Rituximab, a monoclo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozoya, Oluwatobi O., Sokol, Lubomir, Dalia, Samir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913070/ https://www.ncbi.nlm.nih.gov/pubmed/27350944 http://dx.doi.org/10.14218/JCTH.2016.00005

Ejemplares similares

Hepatitis B Reactivation in the Treatment of Non-Hodgkin Lymphoma
por: Kelling, Matthew, et al.
Publicado: (2018)

The impact of hepatitis B virus and hepatitis C virus infections in patients with Hodgkin's and non-Hodgkin’s lymphoma
por: Kadry, Dalia Y, et al.
Publicado: (2023)

Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy
por: Grover, Natalie S., et al.
Publicado: (2015)

HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies
por: Cao, Xing, et al.
Publicado: (2021)

Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment
por: Juárez-Salcedo, Luis Miguel, et al.
Publicado: (2018)

Hepatitis Virus-associated Non-hodgkin Lymphoma: Pathogenesis and Treatment Strategies
por: Zhang, Wenjing, et al.
Publicado: (2023)

Long-term Outcome after Prophylactic Lamivudine Treatment on Hepatitis B Virus Reactivation in Non-Hodgkin's Lymphoma
por: Kim, Jin Seok, et al.
Publicado: (2007)

Targeted Agents in the Treatment of Indolent B-Cell Non-Hodgkin Lymphomas
por: Minson, Adrian, et al.
Publicado: (2022)

Perspectives and Practice of HIV Disclosure to Children and Adolescents by Health-Care Providers and Caregivers in sub-Saharan Africa: A Systematic Review
por: Aderomilehin, Oluyemisi, et al.
Publicado: (2016)

Rapid Regression of B-Cell Non-Hodgkin's Lymphoma after Eradication of Hepatitis C Virus by Direct Antiviral Agents
por: Hirose, Shunji, et al.
Publicado: (2019)

Vascular patterns in reactive lymphoid tissue and in non-Hodgkin's lymphoma
por: Passalidou, E, et al.
Publicado: (2003)

Progressive Multifocal Leukoencephalopathy and Monoclonal Antibodies: A Review
por: Bohra, Chandrashekar, et al.
Publicado: (2017)

Novel Agents For Relapsed and Refractory Classical Hodgkin Lymphoma: A Review
por: Zhang, Yujie, et al.
Publicado: (2022)

Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies
por: Ricci, Jean-Ehrland, et al.
Publicado: (2018)

Hepatitis C Virus Cryoglobulinemia and Non-Hodgkin Lymphoma
por: Jadali, Zohreh
Publicado: (2012)

New agents in relapsed/refractory Hodgkin's lymphoma()
por: Biasoli, Irene, et al.
Publicado: (2017)

Expression of PAX-5 in B Cell Hodgkin and Non Hodgkin Lymphoma
por: Khan, Muhammad Rahil, et al.
Publicado: (2018)

Radioimmunotherapy of B-Cell Non-Hodgkin’s Lymphoma
por: Bodet-Milin, Caroline, et al.
Publicado: (2013)

A novel immunomodulatory and molecularly targeted strategy for refractory Hodgkin's lymphoma
por: Subbiah, Vivek, et al.
Publicado: (2013)

Prevalence of Hepatitis C virus Genotype 3a in patients with Hodgkin and Non-Hodgkin Lymphoma
por: Radmehr, Hashem, et al.
Publicado: (2016)

Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma
por: De Vita, S, et al.
Publicado: (1998)

Hepatitis C virus and non-Hodgkin’s lymphomas: A minireview
por: Khaled, Hussein, et al.
Publicado: (2017)

Development of Hepatic Steatosis After Chemotherapy for Non‐Hodgkin Lymphoma
por: Ben‐Yakov, Gil, et al.
Publicado: (2018)

Immunotherapeutic Strategies for Canine Lymphoma: Changing the Odds Against Non-Hodgkin Lymphoma
por: Dias, Joana N. R., et al.
Publicado: (2021)

Effects of chemotherapeutic agent bendamustine for non-hodgkin lymphoma on spermatogenesis in mice
por: Zang, Min-bo, et al.
Publicado: (2018)

Detection of novel and recurrent conjoined genes in non-Hodgkin B-cell lymphoma
por: Matsumoto, Yosuke, et al.
Publicado: (2021)

Non-Hodgkin's Lymphomas
por: Proctor, S.J.
Publicado: (1994)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

Integrating Novel Agents in Relapsed or Refractory Hodgkin Lymphoma: Highlights From SOHO 2020
Publicado: (2021)

Novel Therapies for Follicular Lymphoma and Other Indolent Non-Hodgkin Lymphomas
por: Leslie, Lori A.
Publicado: (2021)

P1531: TIXAGEVIMAB-CILGAVIMAB THERAPY IN THE PREVENTION OF SARS-COV2 INFECTION IN NON-HODGKIN-B LYMPHOMAS AND HODGKIN LYMPHOMAS UNDER TREATMENT: OUR EXPERIENCE
por: Pezzullo, Luca, et al.
Publicado: (2023)

Constitutive overexpression of a novel 21 kDa protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas
por: Zhou, Minglong, et al.
Publicado: (2008)

Prevalence of hepatitis B and hepatitis C viral infections in various subtypes of B-cell non-Hodgkin lymphoma: confirmation of the association with splenic marginal zone lymphoma
por: Xiong, W, et al.
Publicado: (2017)

NFkB Pathway and Hodgkin Lymphoma
por: Jardin, Fabrice
Publicado: (2022)

B-cell non-Hodgkin lymphoma of the ethmoid sinus
por: Tinoco, Paulo, et al.
Publicado: (2015)

Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity
por: Bende, Richard J., et al.
Publicado: (2005)

Male fertility after VAPEC-B chemotherapy for Hodgkin's disease and non-Hodgkin's lymphoma.
por: Radford, J. A., et al.
Publicado: (1994)

B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma
por: Thurner, Lorenz, et al.
Publicado: (2023)

Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management
por: Cannizzaro, Maria Vittoria, et al.
Publicado: (2017)

Hepatitis B Virus Infection and B‐Cell Non‐Hodgkin's Lymphoma in a Hepatitis B Endemic Area: A Case‐control Study
por: Kim, Jee Hyun, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_nafb1m9977mu7bmof85hdmbe24